Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-08-23
2005-08-23
Powers, Fiona T. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S258100, C514S303000, C514S339000, C514S393000, C514S394000, C514S397000, C514S406000, C514S414000, C544S144000, C544S256000, C544S333000, C546S200000, C546S277100, C548S305100, C548S312100, C548S364700, C548S467000
Reexamination Certificate
active
06933295
ABSTRACT:
The invention relates to the field of blood clotting, to novel compounds of formula (I),to a method for their production and to the use of these compounds as active ingredients in medicaments for preventing and/or treating diseases. The compounds are factor Xa inhibitors.
REFERENCES:
patent: 6140351 (2000-10-01), Arnaiz et al.
patent: 2004/0215019 (2004-10-01), Straub et al.
patent: 9906371 (1999-02-01), None
patent: 9900121 (1999-07-01), None
patent: 9937304 (1999-07-01), None
patent: WO-03/011585 (2003-02-01), None
Al-Obeidi, F., and Ostrem, J. A., “Factor Xa Inhibitors”, Exp. Opin. Ther. Patents, 9(7): 931-953 (1999).
Betz, A., “Recent advances in Factor Xa inhibitors”, Exp. Opin. Ther. Patents, 11(6): 1007-1017 (2001).
Hauptmann, et al., “Synthetic Inhibitors of Thrombin and Factor Xa: From Bench to Bedside,” Thrombosis Res.93, 203-241, (1999).
Al-Obeidi, et al., “Factor Xa Inhibitors by Classical and Combinatorial Chemistry”, DDT,3, 223-231, (1998).
Al-Obeidi, et al., “Factor Xa Inhibitors”, Exp. Opin. Ther. Patents9, 931-953, (1999).
Kaiser, “Thrombin and Factor Xa Inhibitors,” Drugs of the Future,23, 423-436, (1998).
Uzan, “Antithrombotic Agents,” Emerging Drugs,3, 189-208, (1998).
Zhu, et al., “Recent Advances in Inhibitors of Factor Xa in the Prothrombinase Complex”, Curr. Opin. in Cardiovas. Pul. & Renal Investigational Drugs,1, 63-88, (1999).
Ullman's Encyclopedia of Industrial Chemistry, Published by VCH Verlagsgesellschaft, Wernheim, 1985-1996; Key word “Vitamin K.”.
Pschyrembel Klinisches Wortherbuch, 257, Published by Walter de Gryuter, 1994, pp. 199-200; Keyword: “Blutgerinnung”.
Pschyrembal Klinisches Worterbuch, 257, Published by Walter de Gruyter, 1994; pp. 610; Keyword: “Heparin”.
Pschyrembel Klinisches Worterbuch, 257, Published by Walter de Gruyter, 1994; pp. 292-293, Keyword: “Cumarinderivate”.
Römpp Lexikon Chemie, Version 1.5, 1998; Georg Thieme, Publisher, Stutgart; Key Word “Blutgerinnung”; Stryer, L., Biochemie, Spectrum der Wissenschaft Verlagsgesellschaft mGH Heidelberg; 1990, pp. 259-260.
Jordan Stephan
Lampe Thomas
Perzborn Elisabeth
Pohlmann Jens
Röhrig Susanne
Bayer Aktiengesellschaft
Powers Fiona T.
LandOfFree
Substituted isoindoles and the use thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted isoindoles and the use thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted isoindoles and the use thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3445088